<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ami_virus_4\PMC7260533\results\search\tropicalVirus\results.xml">
  <result pre="brain. â€¢The genetic variant CCR5Î&quot;32 increases the risk of symptomatic" exact="West Nile" post="virus infection. â€¢The triad â€œCCR5, extracellular vesicles and infectionsâ€�"/>
  <result pre="the CCR5Î&quot;32 in human infections caused by the following pathogens:" exact="West Nile" post="virus, Influenza virus, Human papillomavirus, Hepatitis B virus, Hepatitis"/>
  <result pre="virus, Human papillomavirus, Hepatitis B virus, Hepatitis C virus, Poliovirus," exact="Dengue" post="virus, Human cytomegalovirus, Crimean-Congo hemorrhagic fever virus, Enterovirus, Japanese"/>
  <result pre="â€œCCR5 researchâ€� are briefly described, with focus on Rocio virus," exact="Zika" post="virus, Epstein-Barr virus, and Rhinovirus. Finally, the potential influence"/>
  <result pre="the effects of the CCR5Î&quot;32 in human viral infections, covering" exact="West Nile" post="virus, Influenza viruses, Human papillomavirus, Hepatitis B virus, Hepatitis"/>
  <result pre="viruses, Human papillomavirus, Hepatitis B virus, Hepatitis C virus, Poliovirus," exact="Dengue" post="virus, Human cytomegalovirus, Crimean-Congo hemorrhagic fever virus, Enterovirus, Japanese"/>
  <result pre="researchâ€� are briefly discussed, with a focus on Rocio virus," exact="Zika" post="virus, Epstein-Barr virus, and Rhinovirus. Studies involving HIV will"/>
  <result pre="was established that the review would address the following viruses:" exact="West Nile" post="virus, Influenza viruses, Human papillomavirus, Hepatitis B virus, Hepatitis"/>
  <result pre="viruses, Human papillomavirus, Hepatitis B virus, Hepatitis C virus, Poliovirus," exact="Dengue" post="virus, Human cytomegalovirus, Crimean-Congo hemorrhagic fever virus, Enterovirus, Japanese"/>
  <result pre="hemorrhagic fever virus, Enterovirus, Japanese encephalitis virus, Hantavirus, Rocio virus," exact="Zika" post="virus, Epstein-Barr virus, and Rhinovirus. All original articles that"/>
  <result pre="in the cited article. 3 CCR5Î&quot;32 and viral infections 3.1" exact="West Nile" post="virus West Nile virus (WNV) is a neurotropic positive-sense"/>
  <result pre="article. 3 CCR5Î&quot;32 and viral infections 3.1 West Nile virus" exact="West Nile" post="virus (WNV) is a neurotropic positive-sense single-stranded RNA flavivirus"/>
  <result pre="single-stranded RNA flavivirus endemic in various parts of the world." exact="WNV" post="transmission to humans occurs through the bite of infected"/>
  <result pre="et al., 2013). Although different animals can participate in the" exact="WNV" post="transmission cycle, birds are the classic amplifier hosts. Humans,"/>
  <result pre="et al., 2008). About 25 % of WNV-infected individuals develop" exact="West Nile" post="fever, a clinical condition with variable symptoms and severity."/>
  <result pre="and severity. In less than 1% of the infected individuals," exact="WNV" post="invades the central nervous system (CNS), causing neurological manifestations"/>
  <result pre="disease), including meningitis, encephalitis, and acute flaccid paralysis. Of note," exact="West Nile" post="neuroinvasive disease shows a 10%â€&quot;20% fatality rate. Severe illness"/>
  <result pre="factors, including genetic traces (Petersen et al., 2013; Sejvar, 2016)." exact="WNV" post="infection is considered the leading cause of arboviral encephalitis"/>
  <result pre="arboviral encephalitis in the world (Ciota, 2017). The treatment of" exact="WNV" post="infection is supportive (Petersen et al., 2013). It is"/>
  <result pre="that the CCR5 protein interferes in the clinical course of" exact="WNV" post="infection (Glass et al., 2005; Diamond, 2009; Michlmayr and"/>
  <result pre="al. (2015), CCR5Î&quot;32 has no important effect on susceptibility to" exact="WNV" post="infection. In accordance, Loeb et al. (2011) found no"/>
  <result pre="Loeb et al. (2011) found no association between CCR5Î&quot;32 and" exact="WNV" post="infection. Conversely, there is robust population-based data showing a"/>
  <result pre="the CCR5Î&quot;32 homozygous genotype and increased risk of developing symptomatic" exact="WNV" post="infection (Glass et al., 2006; Lim et al., 2008,"/>
  <result pre="(2011) showed that the CCR5Î&quot;32 variant was associated with symptomatic" exact="WNV" post="infection when the dominant model of inheritance was considered"/>
  <result pre="recent meta-analysis confirmed the role of the CCR5 gene in" exact="WNV" post="infection, specifically the association between the CCR5Î&quot;32 with severe"/>
  <result pre="evaluated the CCR5Î&quot;32 genetic variant in the context of human" exact="WNV" post="infection. Table 1 Impacts of CCR5Î&quot;32 on West Nile"/>
  <result pre="of human WNV infection. Table 1 Impacts of CCR5Î&quot;32 on" exact="West Nile" post="virus (WNV) infection. Table 1 Population Sample Main findings"/>
  <result pre="homozygous genotype was strongly associated with increased risk of symptomatic" exact="WNV" post="infection Glass et al. (2006) American 224 symptomatic WNVâ€¯+â€¯individuals;"/>
  <result pre="homozygous genotype was strongly associated with increased risk of symptomatic" exact="WNV" post="infection Lim et al. (2008) American 634 WNVâ€¯+â€¯individuals; 422"/>
  <result pre="individuals CCR5Î&quot;32 homozygous genotype was associated with clinical symptoms of" exact="WNV" post="infection; No association between CCR5Î&quot;32 and susceptibility to WNV"/>
  <result pre="of WNV infection; No association between CCR5Î&quot;32 and susceptibility to" exact="WNV" post="infection Lim et al. (2010) American, Canadian 385 symptomatic"/>
  <result pre="from Glass et al. (2006)] No association of CCR5Î&quot;32 and" exact="WNV" post="infection considering symptomatic and asymptomatic WNVâ€¯+â€¯individuals; Considering a dominant"/>
  <result pre="Glass et al. (2006), the CCR5Î&quot;32 was associated with symptomatic" exact="WNV" post="infection and infection risk Bigham et al. (2011) American,"/>
  <result pre="1233 individuals with non-severe infection No association between CCR5Î&quot;32 and" exact="WNV" post="infection severity Loeb et al. (2011) Israeli (Ashkenazi Jews)"/>
  <result pre="symptomatic WNVâ€¯+â€¯individuals; 61 non-infected individuals No association between CCR5Î&quot;32 and" exact="WNV" post="infection Danial-Farran et al. (2015) In agreement with studies"/>
  <result pre="that CCR5Î&quot;32 homozygous genotype is a risk factor for symptomatic" exact="WNV" post="infection in humans, Ccr5-/- WNV-infected mice showed a reduced"/>
  <result pre="Ccr5 is a key molecule in the immune response against" exact="WNV" post="(Glass et al., 2005; Durrant et al., 2015). Taking"/>
  <result pre="support the role of CCR5 as a protective molecule on" exact="WNV" post="pathogenesis. Specifically, CCR5+ leukocytes play a fundamental role in"/>
  <result pre="pathogenesis. Specifically, CCR5+ leukocytes play a fundamental role in combating" exact="WNV" post="in the brain (Glass et al., 2005; Lim et"/>
  <result pre="sense, CCR5 plays a specific and non-redundant role in controlling" exact="WNV" post="infection (Lim and Murphy, 2011; Durrant et al., 2015;"/>
  <result pre="effects of the CCR5Î&quot;32 genetic variant on both HIV and" exact="WNV" post="infections are summarized in Fig. 5 . Hereupon, individuals"/>
  <result pre="homozygous for CCR5Î&quot;32 and living in endemic areas of the" exact="WNV" post="should take additional care to prevent WNV infection (e.g.,"/>
  <result pre="areas of the WNV should take additional care to prevent" exact="WNV" post="infection (e.g., use of repellents, mosquito nets). Also, the"/>
  <result pre="Fig. 5 Effects of the polymorphism CCR5Î&quot;32 on HIV and" exact="WNV" post="infections. Upper panel: effects observed in individuals with the"/>
  <result pre="is a double-stranded DNA virus belonging to the papillomavirus family." exact="HPV" post="is transmitted by direct contact (for example, through sexual"/>
  <result pre="transmitted by direct contact (for example, through sexual intercourse). The" exact="HPV" post="infection is quite common worldwide, and is usually controlled"/>
  <result pre="years after infection. However, if the infection is not controlled," exact="HPV" post="can cause non-cancerous mucosal lesions or different types of"/>
  <result pre="vulvar cancer, head cancer, neck cancer, and especially cervical cancer." exact="HPV" post="is an oncogenic pathogen because it inhibits the activity"/>
  <result pre="5â€&quot;10 % of all cancers in women are due to" exact="HPV" post="infection (Schiffman et al., 2016; SanjosÃ© et al., 2018)."/>
  <result pre="et al., 2016; SanjosÃ© et al., 2018). There are several" exact="HPV" post="genotypes (&amp;gt;200), and those most associated with cancer are:"/>
  <result pre="Vaccination is one of the most effective ways to prevent" exact="HPV" post="infection, having important positive impacts on multiple aspects of"/>
  <result pre="having important positive impacts on multiple aspects of population health." exact="HPV" post="vaccine protects the vaccinated individual from infection per se"/>
  <result pre="genotype was associated with stage 1B of cervical cancer. The" exact="HPV" post="positivity rate among the evaluated patients was not described"/>
  <result pre="not described (Singh et al., 2008). The relationship between CCR5Î&quot;32," exact="HPV" post="infection, and cervical lesions is addressed in other studies"/>
  <result pre="). CCR5Î&quot;32 homozygous genotype was associated with increased susceptibility to" exact="HPV" post="infection in a study performed with Swedish individuals (Zheng"/>
  <result pre="(2019) investigated the potential influence of CCR5Î&quot;32 on susceptibility to" exact="HPV" post="infection and cervical lesions in Brazilian women. However, the"/>
  <result pre="the genetic variant was not significantly associated with susceptibility to" exact="HPV" post="infection (considering allele frequency, codominant model and dominant model)"/>
  <result pre="did not find an association between CCR5Î&quot;32 and susceptibility to" exact="HPV" post="infection (Suzuki et al., 2008) or between the polymorphism"/>
  <result pre="et al., 2016). Lastly, CCR5Î&quot;32 did not affect susceptibility to" exact="HPV" post="infection in Lithuanian individuals with laryngeal cancer (StumbrytÄ—-KaminskienÄ— et"/>
  <result pre="to a lack of involvement of CCR5Î&quot;32 in susceptibility to" exact="HPV" post="infection or HPV-associated diseases. Table 3 Impacts of CCR5Î&quot;32"/>
  <result pre="individuals CCR5Î&quot;32 homozygous genotype was associated with increased risk of" exact="HPV" post="infection Zheng et al. (2006) Brazilian 74 HPV-infected individuals;"/>
  <result pre="HPV-infected individuals; 43 non-infected individuals No association between CCR5Î&quot;32 and" exact="HPV" post="infection; No association between CCR5Î&quot;32 and HPV-related cancer Suzuki"/>
  <result pre="between CCR5Î&quot;32 and HPV-related lesions; No association between CCR5Î&quot;32 and" exact="HPV" post="genotypes Santos et al. (2016) Brazilian 164 HPV-infected individuals;"/>
  <result pre="individuals No statistically significant effect of CCR5Î&quot;32 on susceptibility to" exact="HPV" post="infection or HPV-related cervical lesions (lowâ€�grade squamous intraepithelial lesion"/>
  <result pre="patients) No statistically significant effect of CCR5Î&quot;32 on susceptibility to" exact="HPV" post="infection, clinical-pathological characteristics or surviving rates StumbrytÄ—-KaminskienÄ— et al."/>
  <result pre="neurologic disease (small sample size study) Rosenberg et al. (2013)" exact="Dengue" post="virus (DENV) infection Brazilian 87 DENV-infected children (severe cases);"/>
  <result pre="(severe cases); 326 controls No statistical association between CCR5Î&quot;32 and" exact="DENV" post="infection Xavier-Carvalho et al. (2013) Australian 56 DENV-infected individuals;"/>
  <result pre="individuals; 91 non-infected individuals No statistical association between CCR5Î&quot;32 and" exact="DENV" post="infection Brestovac et al. (2014) Indian 42 DENV-infected individuals"/>
  <result pre="associated with more severe disease Kletenkov et al. (2019) 3.7" exact="Dengue" post="virus Dengue virus (DENV) is a single-stranded RNA virus"/>
  <result pre="more severe disease Kletenkov et al. (2019) 3.7 Dengue virus" exact="Dengue" post="virus (DENV) is a single-stranded RNA virus that belongs"/>
  <result pre="belongs to the Flaviviridae family, Flavivirus genus. There are four" exact="DENV" post="serotypes, being all transmitted to humans by Aedes mosquitoes"/>
  <result pre="mosquitoes (Aedes aegypti and Aedes albopictus) (Guzman et al., 2016)." exact="DENV" post="infection is a global health problem with huge impacts"/>
  <result pre="world (Stanaway et al., 2016). Globally, the incidence of symptomatic" exact="DENV" post="infection is within the range of 50â€&quot;100 million cases"/>
  <result pre="phases: acute febrile phase, critical phase, and recovery (convalescent) phase." exact="Dengue" post="disease occurs with/without warning signs or severe dengue. Warning"/>
  <result pre="signals and symptoms (Guzman et al., 2016). Infection with a" exact="DENV" post="serotype triggers long-term immunity to that specific serotype (homotypic"/>
  <result pre="immunity to that specific serotype (homotypic DENV). Immunity to heterotypic" exact="DENV" post="also occurs, but it is transitory. Therefore, an individual"/>
  <result pre="2011; St John and Rathore, 2019). The immune response mediates" exact="DENV" post="clearance and the resolution of dengue diseases, but it"/>
  <result pre="suggests the participation of CCL5/CCR5 axis in the protection against" exact="DENV" post="(Sierra et al., 2014), as well as in the"/>
  <result pre="et al., 2014), as well as in the pathogenesis of" exact="Dengue" post="disease (Islam et al., 2019). Indeed, DENV infection is"/>
  <result pre="the pathogenesis of Dengue disease (Islam et al., 2019). Indeed," exact="DENV" post="infection is associated with increased frequency of human CCR5â€¯+â€¯T"/>
  <result pre="blockers. In the same study, CCR5-/- mice were protected from" exact="DENV" post="infection. These findings suggest that CCR5Î&quot;32 could be a"/>
  <result pre="findings suggest that CCR5Î&quot;32 could be a protective factor against" exact="DENV" post="infection. However, Xavier-Carvalho et al. (2013) found no statistical"/>
  <result pre="the frequency of CCR5Î&quot;32 polymorphism between Brazilian children with severe" exact="DENV" post="infection and healthy controls. In the same direction, no"/>
  <result pre="the same direction, no effect of CCR5Î&quot;32 on susceptibility to" exact="DENV" post="infection was found in a small sample-size study performed"/>
  <result pre="no important involvement of CCR5 gene or CCR5 polymorphisms in" exact="DENV" post="infection (Cahill et al., 2018; Ornelas et al., 2019)."/>
  <result pre="6 shows some details of the studies involving CCR5Î&quot;32 and" exact="DENV" post="infection. Taking together, the data mentioned above indicate that"/>
  <result pre="data mentioned above indicate that the effects of CCR5 on" exact="DENV" post="infection are very different between humans and rodents. However,"/>
  <result pre="cannot exclude some potential effects of CCR5 and CCR5Î&quot;32 on" exact="DENV" post="infection in humans. 3.8 Human cytomegalovirus Human cytomegalovirus (CMV)"/>
  <result pre="absence of CCR5 due to CCR5Î&quot;32 is considered deleterious in" exact="WNV" post="infection (Glass et al., 2006; Lim et al., 2008)"/>
  <result pre="infection) and living in areas endemic for neuroinvasive viruses, especially" exact="WNV" post="and TBEV, may be at increased risk of developing"/>
  <result pre="(Martin-Blondel et al., 2016). As mentioned in the topic addressing" exact="WNV" post="in this review, it is prudent to recommend to"/>
  <result pre="of mosquito repellents and mosquito nets (considering the risk of" exact="WNV" post="infection), and to limit their exposure to tick-infested areas"/>
  <result pre="extent) in the context of the following viruses: Bunyaviruses, Cytomegalovirus," exact="Dengue" post="virus (DENV), Ebola virus, Epstein-Barr virus, Hepatitis A virus,"/>
  <result pre="simplex virus, Human T cell lymphotropic virus, Kaposiâ€™s sarcoma-associated herpesvirus," exact="Zika" post="virus (ZIKV), TBEV, HIV (Kaminski et al., 2019b), and"/>
  <result pre="(Zhou et al., 2018). Exosomes have shown multi-dimensional roles in" exact="DENV" post="life cycle. They can modulate negatively or positively DENV"/>
  <result pre="in DENV life cycle. They can modulate negatively or positively" exact="DENV" post="pathogenesis, where they are suggested as instrumental for Dengue"/>
  <result pre="positively DENV pathogenesis, where they are suggested as instrumental for" exact="Dengue" post="Hemorrhagic Fever development in reason of the transportation of"/>
  <result pre="6 Neglected and emerging topics in CCR5 research: Rocio virus," exact="Zika" post="virus, Epstein-Barr virus, and rhinovirus ChÃ¡vez et al. (2013)"/>
  <result pre="Silva et al., 2014). Badolato-CorrÃªa et al. (2018) reported that" exact="Zika" post="virus (ZIKV) infection induces an upregulation of CCR5 expression"/>
  <result pre="an upregulation of CCR5 expression on T cells. Of note," exact="ZIKV" post="is another mosquito-borne flavivirus that recently reemerged in many"/>
  <result pre="that recently reemerged in many countries, affecting Brazil in particular." exact="ZIKV" post="infection is associated with microcephaly and other human development"/>
  <result pre="of cytokines and chemokines are associated with several aspects of" exact="ZIKV" post="(Barros et al., 2018; Naveca et al., 2018; Khaiboullina"/>
  <result pre="For instance, the CCR5Î&quot;32 does not significantly affect susceptibility to" exact="WNV" post="infection. However, the effect of the CCR5 and CCR5Î&quot;32"/>
  <result pre="infection. However, the effect of the CCR5 and CCR5Î&quot;32 on" exact="WNV" post="disease progression is very robust. Some animal-derived findings suggest"/>
  <result pre="suggest the involvement of the CCR5 in the pathogenesis of" exact="DENV" post="infection. However, the effects of CCR5 on DENV infection"/>
  <result pre="pathogenesis of DENV infection. However, the effects of CCR5 on" exact="DENV" post="infection are very different between humans and rodents. Of"/>
  <result pre="rodents. Of note, CCR5Î&quot;32 does not significantly affect susceptibility to" exact="DENV" post="infection or disease progression. Moreover, the effect of CCR5Î&quot;32"/>
  <result pre="effects in certain conditions, such as increased susceptibility to symptomatic" exact="WNV" post="infection. Finally, this article showed that the participation of"/>
  <result pre="Filippis AMBispoVenÃ¢ncio da CunhaR.Leal de AzeredoE.de-Oliveira-PintoL.M.Human T cell responses to" exact="Dengue" post="and Zika virus infection compared to Dengue/Zika coinfectionImmun. Inflamm."/>
  <result pre="da CunhaR.Leal de AzeredoE.de-Oliveira-PintoL.M.Human T cell responses to Dengue and" exact="Zika" post="virus infection compared to Dengue/Zika coinfectionImmun. Inflamm. Dis.6201819420610.1002/iid3.20329282904 BadorffC.LeeG.H.KnowltonK.U.Enteroviral"/>
  <result pre="in the pathogenesis of neurotropic flavivirusesImmunol. Res.54201212113210.1007/s12026-012-8333-322547394 BarrosJ.B.S.da SilvaP.A.N.KogaR.C.R.Gonzalez-DiasP.Carmo FilhoJ.R.NagibP.R.A.CoelhoV.NakayaH.I.FonsecaS.G.PfrimerI.A.H.Acute" exact="Zika" post="virus infection in an endemic area shows modest proinflammatory"/>
  <result pre="proinflammatory systemic immunoactivation and cytokine-symptom associationsFront. Immunol.9201882110.3389/fimmu.2018.0082129774022 BaudD.GublerD.J.SchaubB.LanteriM.C.MussoD.An update on" exact="Zika" post="virus infectionLancet39020172099210910.1016/S0140-6736(17)31450-228647173 BenteD.A.ForresterN.L.WattsD.M.McAuleyA.J.WhitehouseC.A.BrayM.Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical"/>
  <result pre="distribution and burden of dengueNature496201350450710.1038/nature1206023563266 BighamA.W.BuckinghamK.J.HusainS.EmondM.J.BofferdingK.M.GildersleeveH.RutherfordA.AstakhovaN.M.PerelyginA.A.BuschM.P.MurrayK.O.SejvarJ.J.GreenS.KrieselJ.BrintonM.A.BamshadM.Host genetic risk factors for" exact="West Nile" post="virus infection and disease progressionPLoS One62011e2474510.1371/journal.pone.0024745 BineshianF.HosseiniA.SharifiZ.AghaieA.A Study on"/>
  <result pre="Ago2-miR122-HSP90PLoS Pathog.102014e100442410.1371/journal.ppat.1004424 CahillM.E.ConleyS.DeWanA.T.MontgomeryR.R.Identification of genetic variants associated with dengue or" exact="West Nile" post="virus disease: a systematic review and meta-analysisBMC Infect. Dis.18201828210.1186/s12879-018-3186-629929468"/>
  <result pre="Med.380201989789910.1056/NEJMp190050430649993 Danial-FarranN.EghbariaS.SchwartzN.Kra-OzZ.BisharatN.Genetic variants associated with susceptibility of Ashkenazi Jews to" exact="West Nile" post="virus infectionEpidemiol. Infect.143201585786310.1017/S095026881400129024865988 DavisA.S.W.RoozenH.N.DufortM.J.DeBergH.A.DelaneyM.A.MairF.EricksonJ.R.SlichterC.K.BerksonJ.D.KlockA.M.MackM.LwoY.KoA.BrandR.M.McGowanI.LinsleyP.S.DixonD.R.PrlicM.The human tissue-resident CCR5+ T cell"/>
  <result pre="region of North IndiaJ. Neuroimmunol.336201957704310.1016/j.jneuroim.2019.577043 DiamondM.S.Virus and host determinants of" exact="West Nile" post="virus pathogenesisPLoS Pathog.52009e100045210.1371/journal.ppat.1000452 DobaczewskiM.XiaY.BujakM.Gonzalez-QuesadaC.FrangogiannisN.G.CCR5 signaling suppresses inflammation and reduces"/>
  <result pre="the chemokine receptor CC-CKR-5Nature381199666767310.1038/381667a08649512 DurrantD.M.DanielsB.P.PasiekaT.DorseyD.KleinR.S.CCR5 limits cortical viral loads during" exact="West Nile" post="virus infection of the central nervous systemJ. Neuroinflammation12201523310.1186/s12974-015-0447-926667390 Ehlin-HenrikssonB.LiangW.CagigiA.MowafiF.KleinG.NilssonA.Changes"/>
  <result pre="CCR5 promotes leukocyte trafficking to the brain and survival in" exact="West Nile" post="virus infectionJ. Exp. Med.20220051087109810.1084/jem.2004253016230476 GlassW.G.McDermottD.H.LimJ.K.LekhongS.YuS.F.FrankW.A.PapeJ.CheshierR.C.MurphyP.M.CCR5 deficiency increases risk of"/>
  <result pre="virus infectionJ. Exp. Med.20220051087109810.1084/jem.2004253016230476 GlassW.G.McDermottD.H.LimJ.K.LekhongS.YuS.F.FrankW.A.PapeJ.CheshierR.C.MurphyP.M.CCR5 deficiency increases risk of symptomatic" exact="West Nile" post="virus infectionJ. Exp. Med.2032006354010.1084/jem.2005197016418398 GouldingC.McManusR.MurphyA.MacDonaldG.BarrettS.CroweJ.HegartyJ.McKiernanS.KelleherD.The CCR5-Î&quot;32 mutation: impact on"/>
  <result pre="Lond.820112910.1186/1476-9255-8-2922029606 IslamM.KalitaT.SaikiaA.K.BegumA.BaruahV.SinghN.BorkotokyR.BoseS.Significance of RANTES-CCR5 axis and linked downstream immunomodulation in" exact="Dengue" post="pathogenesis: A study from Guwahati, IndiaJ. Med. Virol.9120192066207310.1002/jmv.2556131368534 JohnsonE.L.HowardC.L.ThurmanJ.PontiffK.JohnsonE.L.S.ChakrabortyR.Cytomegalovirus"/>
  <result pre="pandemic (H1N1) 2009Emerg Infect Dis1620101621162210.3201/eid1610.10010820875295 KhaiboullinaS.F.LopesP.de CarvalhoT.G.RealA.L.C.V.SouzaD.G.CostaV.V.TeixeiraM.M.BloiseE.VermaS.C.RibeiroF.M.Host immune response to" exact="ZIKV" post="in an immunocompetent embryonic mouse model of intravaginal infectionViruses11201955810.3390/v11060558"/>
  <result pre="C in JapanIntervirology47200411412010.1159/00007783515192276 KramerL.D.StyerL.M.EbelG.D.A global perspective on the epidemiology of" exact="West Nile" post="virusAnnu. Rev. Entomol.532008618110.1146/annurev.ento.53.103106.09325817645411 KrammerF.SmithG.J.D.FouchierR.A.M.PeirisM.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.GarcÃ­a-SastreA.InfluenzaNat. Rev. Dis. Primers42018310.1038/s41572-018-0002-y29955068 KÃ¼hlU.PauschingerM.SeebergB.LassnerD.NoutsiasM.PollerW.SchultheissH.P.Viral persistence"/>
  <result pre="with chronic hepatitis C infectionJ. Infect. Dis.18520021803180710.1086/34082912085329 LimJ.K.MurphyP.M.Chemokine control of" exact="West Nile" post="virus infectionExp. Cell Res.317201156957410.1016/j.yexcr.2011.01.00921376172 LimJ.K.GlassW.G.McDermottD.H.MurphyP.M.CCR5: no longer a â€˜good"/>
  <result pre="LimJ.K.GlassW.G.McDermottD.H.MurphyP.M.CCR5: no longer a â€˜good for nothingâ€™ gene--chemokine control of" exact="West Nile" post="virus infectionTrends Immunol.27200630831210.1016/j.it.2006.05.00716753343 LimJ.K.LouieC.Y.GlaserC.JeanC.JohnsonB.JohnsonH.McDermottD.H.MurphyP.M.Genetic deficiency of chemokine receptor CCR5"/>
  <result pre="chemokine receptor CCR5 is a strong risk factor for symptomatic" exact="West Nile" post="virus infection: a meta-analysis of 4 cohorts in the"/>
  <result pre="deficiency is a risk factor for early clinical manifestations of" exact="West Nile" post="virus infection but not for viral transmissionJ. Infect. Dis.201201017818510.1086/64942620025530"/>
  <result pre="profile from human infected neuroprogenitor cells is strongly correlated to" exact="Zika" post="virus microcephaly cytokines phenotype evidencing a persistent inflammation in"/>
  <result pre="mouse modelCytokine1102018707710.1016/j.cyto.2018.04.02229704821 LoebM.EskandarianS.RuppM.FishmanN.GasinkL.PattersonJ.BramsonJ.HudsonT.J.LemireM.Genetic variants and susceptibility to neurological complications following" exact="West Nile" post="virus infectionJ. Infect. Dis.20420111031103710.1093/infdis/jir49321881118 LoefflerJ.SteffensM.ArltE.M.ToliatM.R.MezgerM.SukA.WienkerT.F.HebartH.NÃ¼rnbergP.BoeckhM.LjungmanP.TrenschelR.EinseleH.Polymorphisms in the genes encoding"/>
  <result pre="and CCR5-Î&quot;32/Î&quot;32Gastroenterology124200386886910.1053/gast.2003.5013412612938 MangieriL.F.L.SenaM.M.Cezar-Dos-SantosF.TrugiloK.P.OkuyamaN.C.M.PereiraÃ‰R.MariaG.C.Q.WatanabeM.A.E.de OliveiraK.B.CCR5 genetic variants and epidemiological determinants for" exact="HPV" post="infection and cervical premalignant lesionsInt. J. Immunogenet.46201933133810.1111/iji.1244431183980 MarkotiÄ‡A.HensleyL.DaddarioK.SpikK.AndersonK.SchmaljohnC.Pathogenic hantaviruses"/>
  <result pre="NavecaF.G.PontesG.S.ChangA.Y.da SilvaG.A.V.do NascimentoV.A.Analysis of the immunological biomarker profile during acute" exact="Zika" post="virus infection reveals the overexpression of CXCL10, a chemokine"/>
  <result pre="view from BrusselsFront. Immunol.6201529510.3389/fimmu.2015.0029526106394 Pauvolid-CorrÃªaA.CamposZ.JulianoR.VelezJ.NogueiraR.M.R.KomarN.Serological evidence of widespread circulation of" exact="West Nile" post="virus and other flaviviruses in equines of the PantanalBrazil."/>
  <result pre="of acute hepatitis B infectionImmunol. Cell Biol.97201931732510.1111/imcb.1222130536991 StumbrytÄ—-KaminskienÄ—A.GudleviÄ�ienÄ—Å½DabkeviÄ�ienÄ—D.MackeviÄ�ienÄ—I.Combined effect of" exact="HPV" post="and several gene SNPs in laryngeal cancerMedicina Kaunas (Kaunas)5620208110.3390/medicina56020081"/>
 </snippets>
</snippetsTree>
